http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP13013087-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
filingDate 2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_698df1540d8f226e0a326862813e8cd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6928d8a4792fe0dda19e4c22a6e30f07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_850a329a7cf7a8e0362187d34f43d449
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de2c2270d43bb7927a62eb96afcdf351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff0103650c9db3e0237aef57519ba84e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26bc73313581de05a711a7f81fc4b5e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ee9fdcbe707d46f5027bea35b430a0a
publicationDate 2014-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP13013087-A
titleOfInvention COMPOUNDS FOR ADDICTION TREATMENT
abstract New compounds having the structure of Formula (I) are disclosed: which are useful for treating dependence on addiction substances in mammals, for example addiction to a dopamine producing agent such as cocaine, morphine, amphetamines, nicotine, and / or alcohol. Pharmaceutical compositions comprising a therapeutically effective amount of a compound of Formula (I) and methods of using the compounds of Formula (I) in the treatment of addiction to a dopamine producing agent are also described.
priorityDate 2011-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507808
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110

Total number of triples: 43.